Gregory W Roloff

10PUBLICATIONS

55CO-AUTHORS

PhysiotherapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunityMedical biotechnology diagnostics (incl. biosensors)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 25, 2026

Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

|May 19, 2026

Consensus Recommendations for CAR T-Cell Administration in Adult Acute Lymphoblastic Leukemia: a Modified Delphi Study.

|Feb 05, 2026

Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Oct 06, 2025

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Yannis K Valtis, Chenyu Lin, David Nemirovsky

|May 07, 2025

Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.

Ibrahim N Muhsen, Gregory W Roloff, Rawan Faramand

|Mar 24, 2025

Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy.

Hannah Lust, Liora M Schultz, Soyang Kwon

Pageof 2

Frequent Collaborators

Lori S Muffly

Aaron C Logan

Noelle V Frey

Joshua Sasine

Kaitlyn C Dykes

Bijal D Shah

Talal Hilal

Jessica T Leonard

Anjali S Advani

Nikeshan Jeyakumar

Frequent Collaborators

Lori S Muffly

Aaron C Logan

Noelle V Frey

Joshua Sasine